Abstract: A flow control apparatus comprising a housing capable of receiving a portion of the feeding set, a pumping device configured to receive the feeding set and may produce a fluid flow in the feeding set and deliver fluid to a subject, an ultrasonic sensor may be configured to produce a sensor signal indicative of a condition of the feeding set, and a control circuit in communication with the ultrasonic sensor for receiving the sensor signal from the ultrasonic sensor indicative of the condition of the feeding set. The ultrasonic sensor may comprise a plurality of sensor components which may be configured to emit an ultrasonic signal in a first direction, and in a second direction opposite the first direction through the feeding set.

Abstract: A hair conditioner composition the exploits a blend of a polyquaternium silicone nanoemulsion and a silicone oil to provide improved conditioning benefits and composition stability. The composition may also include a cationic surfactant, a fatty alcohol, and an aqueous carrier. When the polyquaternium silicone nanoemulsion and silicone oil are blended at the right ratio, the composition provides improved hair free flow and exhibits good stability.

Abstract: A dental polymerizable composition includes a (meth)acrylate compound; and a glass. The glass includes gadolinium.

Abstract: Provided is a composition having an excellent ultraviolet protection effect and being unlikely to cause uneven suntan even if the application is uneven. A film-forming composition contains components (a) and (b): (a) a nonvolatile oil containing an ultraviolet absorber; and (b) a fiber having an average fiber diameter of 0.1 ?m or more and 7 ?m or less in an amount of 0.5 mass % or more and 10 mass % or less in the film-forming composition, and the (average fiber diameter)2/(fiber content) (?m2/mass %) is 0.005 or more and 7 or less.

Abstract: A solidified lotion is provided. The lotion includes a mixture of moisturizers and solidifying agents and forms a solid at room temperature. The lotion is manufactured into solid shapes which each include a single use quantity of lotion. The individual solid shapes are coated with a starch such as arrowroot powder. These individual shapes of solid lotion are sufficiently durable to not deform or stick to each other; allowing a large quantity of the solid lotion shapes to be packaged together without individual wrapping or packaging. During use, the lotion shapes melt when rubbed onto a person's skin and allow for quick absorption into the skin.

Abstract: The present disclosure relates to a cosmetic composition containing an extract of Cyperus rotundus extracted using warm microbubbles. The extract inhibits nitric oxide (NO) production and exhibits excellent anti-inflammatory efficacy by inhibiting the expression of interleukin 6 (IL-6), cyclooxygenase-2 (COX-2), interleukin-1? (IL-1?), and tumor necrosis factor-? (TNF-?), which are inflammatory expression factors. In addition, the extract enhances the expression of aquaporin-3 (AQP-3), hyaluronan synthase 2 (HAS-2), claudin-1 (CLDN-1), cadherin 1 (CDH1), filaggrin (FLG), and involucrin (IVL), which are genes related to the skin barrier and moisturizing. Thus, when using the extract for cosmetic products, excellent effects can be exhibited in skin soothing, moisturizing, enhancement of the skin barrier, relief of irritation such as erythema, relief of pruritus, and the like, so the extract can be usefully applied to multi-care products that improve skin conditions.

Abstract: Disclosed herein are oral hygiene compositions, dental flossing material, and methods of treatment using the same. In some embodiments, the oral hygiene composition comprises a remineralization agent, a prebiotic agent, and an alkalizing agent.

Abstract: Provided herein are, inter alia, compositions, systems, and methods for preventing or treating acne. Included are compositions, combinations, systems, and methods comprising at least one Propionibacterium acnes bacteriophage, at least one anti-acne compound, and a pharmaceutically acceptable carrier. Also included are compositions, combinations, and systems comprising a Propionibacterium acnes bacteriophage and an enzyme. Methods for preventing or treating acne are also provided.

Abstract: The present invention relates to a hair serum and supplement for use in the treatment and/or alleviation of skin and/or hair-related symptoms and/or condition, comprising dandruff, weakening and/or breaking nails or hair, including hair-loss. Treatments may comprise application of a cannabinoid-comprising topical composition, such as a cannabidiol- and low molecular weight alcohol composition e.g. formulated as a serum, and/or consumption of a supplement comprising e.g. vitamins, zinc, selenium and amino acids, such as one or more S-comprising amino acid(s).

Abstract: Devices and methods for treating a vascular disease in a subject are disclosed that involve acute administration of a statin locally to a diseased segment of a blood vessel in the subject.

Abstract: In an embodiment, a moisturizing composition includes a silk solution, wherein the silk solution comprises about 1% to about 10% (w/v) of pure silk fibroin-based protein fragments that are substantially devoid of sericin; hyaluronic acid; an oil or butter; and a pH adjusting agent.

Abstract: Stable, ready-to-use injectable pharmaceutical compositions are provided, comprising the combination of neostigmine, glycopyrrolate, and a pharmaceutically acceptable liquid vehicle, optionally with additional pharmaceutically acceptable excipients. Other aspects of the invention relate to methods for making such compositions and methods of using such compositions for reversing the effects of non-depolarizing neuromuscular blocking agents. Preferably, the composition comprises neostigmine methylsulfate, glycopyrronium bromide, and a pharmaceutically acceptable liquid vehicle, and is provided in a pre-filled, ready-to-use sealed container, such as a pre-filled syringe, suitable for intravenous administration.

Abstract: Disclosed herein are skin care compositions, comprising vitamin E (e.g., alpha-tocopherol), a thiourca derivative of histidine (e.g., ergothioneine), a vitamin B3 compound (e.g., niacinamide) and/or a pyrrolidone carboxylic acid and/or a salt thereof (e.g., sodium PCA) as well as to methods of using these compositions.

Abstract: Pharmaceutical formulations with a tropomyosin-related kinase inhibitor (“Trk inhibitor”) are disclosed. The pharmaceutical formulations comprise 3-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)-6-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5b-]pyridin-2-amine in microcrystalline suspension formulations in its monohydrate form, which shows improved characteristics over the anhydrate form, and in extended release formulations. The extended release pharmaceutical formulations comprise 3-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)-6-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-2-amine-loaded microspheres.

Abstract: A composition for cleansing and/or removing makeups from keratin materials, comprises a)at least one foaming surfactant; b)at least one nonionic cellulose selected from celluloses with at least one OH group substituted by a hydrophobic group; and c)at least one oxidized and esterified starch. A non-therapeutic process for cleansing and/or removing makeups from keratin materials, in particular the skin, comprises the application to the keratin materials, in particular the skin, of the composition, and rinsing off said composition after an optional period of time.

Abstract: The invention provides implantable drug delivery devices comprising a core comprising a polymer (or polymer blend) and one or more drugs or pharmaceutical substances, and an outer shell comprising a polymer (or polymer blend) and one or more porogen materials. The invention reduces burst release of drug. Pharmaceuticals such as triiodothyronine (T3) or ropinirole can be delivered by the devices.

Abstract: The invention relates to a biocompatible product having a crosslinked matrix, in which a polysaccharide is co-crosslinked with chitosan, a chitosan derivative, or a salt of chitosan, said matrix further comprising a divalent zinc cation.

Abstract: The present disclosure relates to, among other things, compositions and methods for improving hardness without using excessive compression forces, thereby preserving compression-sensitive or pressure-sensitive active ingredients. The present disclosure also relates to compositions and methods for preparing post-compression hardening materials having a high tensile strength at low water activity.

Abstract: The present disclosure relates to an additive composition for improving bubble density and bubble elasticity that can enhance overall bubble satisfaction through a combination of natural gums, and a composition for skin cleansing. The composition disclosed herein can simultaneously improve the bubble density and the bubble elasticity of the skin cleanser, thereby enhancing the overall bubble satisfaction with the skin cleanser, and comprises the diutan gum, thereby enabling to improve an amount of the bubbles, the bubble density and the bubble elasticity while maintaining weak acidity.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating obesity, wherein the pharmaceutical composition contains Polygalin C as an active ingredient. The Polygalin C not only reduces the accumulation of lipids by inhibiting the differentiation of preadipocytes into adipocytes, but also inhibits adipose tissue generation factors and adipogenic factors and modulates AMPK/ACC and MAPK/Akt signaling pathways to inhibit the differentiation of adipocytes, and thus can treat obesity more effectively. In addition, the present invention inhibits adipogenic factors and inflammatory factors in a free fatty acid-induced non-alcoholic steatohepatitis (NASH) cell model, and thus can effectively treat and prevent non-alcoholic fatty liver disease (NAFLD) including hepatic steatosis and non-alcoholic steatohepatitis.